Showing 81 - 100 results of 673 for search '"New Zealand"', query time: 0.10s Refine Results
  1. 81
  2. 82

    The Relationship Between Culture and the Modifiable Risk Factors of Dementia Among Indigenous Peoples in Canada, the USA, Australia, and New Zealand: A Scoping Review Protocol by Brittany Skov, Angela M. Ashley, Ishaq Malik, Hannah Storrs, Elaine Toombs, Christopher J. Mushquash

    Published 2025-01-01
    “…Background: Compared to non-Indigenous peoples, the prevalence of dementia is higher among Indigenous Peoples in Canada, the United States, New Zealand, and Australia, and poses significant challenges to individual, family, and community health and well-being. …”
    Get full text
    Article
  3. 83

    Hidden costs of providing care: a pilot study of Japanese migrant care workers’ experiences in Aotearoa New Zealand during the COVID-19 pandemic by Shinya Uekusa

    Published 2025-01-01
    “…Recognising the increasingly vital yet precarious role that Asian migrant care workers (MCWs) play within Aotearoa New Zealand (Aotearoa) health system, this paper delves into the qualitative exploration of the experiences encountered by Japanese MCWs amidst everyday challenges and injustices during the COVID-19 pandemic in Aotearoa. …”
    Get full text
    Article
  4. 84

    Tumor Necrosis Factor Receptor Superfamily, Member 1B Haplotypes Increase or Decrease the Risk of Inflammatory Bowel Diseases in a New Zealand Caucasian Population by Lynnette R. Ferguson, Dug Yeo Han, Claudia Huebner, Ivonne Petermann, Murray L. Barclay, Richard B. Gearry, Alan McCulloch, Pieter S. Demmers

    Published 2009-01-01
    “…This study investigates the role that selected single nucleotide polymorphisms (SNPs) and haplotypes in the TNF-alpha receptor (TNSFRSF1B) gene play in the risk of IBD in a New Zealand Caucasian population. DNA samples from 388 CD, 405 UC, 27 indeterminate colitis patients, and 293 randomly selected controls, from Canterbury, New Zealand were screened for 3 common SNPs in TNSFRSF1B: rs1061622 (c.676T>C), rs1061624 (c.∗1663A>G), and rs3397 (c.∗1690T>C), using TaqMan technologies. …”
    Get full text
    Article
  5. 85

    Extender Supplementation with Glutathione (GSH) and Taurine Improves In Vitro Sperm Quality and Antioxidant Status of New Zealand Rabbits during Chilled Storage for up to 72 hours by Mohamed F. F. Bayomy, Sobhy E. Hassab El-Nabi, Tahany A. El Kassas, Zeinab I. Attia, Ayman M. Saeed, Heba S. A. Taha, Mahmoud Alagawany, Livio Galosi, Lucia Biagini, Seham El-Kassas

    Published 2023-01-01
    “…Semen samples were collected from 20 New Zealand bucks, and ejaculates with standard color, motility (>85%), about 0.5 mL volume, and ∼400 × 106/mL concentration were used and diluted with extenders supplemented with 0.5, 1, and 2 mM of GSH and 1, 5, and 10 mM of taurine and chilled at 5°C. …”
    Get full text
    Article
  6. 86
  7. 87

    Examining reliability of WHOBARS: a tool to measure the quality of administration of WHO surgical safety checklist using generalisability theory with surgical teams from three New Zealand hospitals by Jennifer M Weller, Carmen Skilton, Derryn A Gargiulo, Oleg N Medvedev, Simon J Mitchell, Alan F Merry

    Published 2019-01-01
    “…In this context, extending reliability refers to establishing generalisability of the tool scores across populations of teams and raters by accounting for the relevant sources of measurement errors.Design Cross-sectional random effect measurement design assessing surgical teams by the five items on the three Checklist phases, and at three sites by two trained raters simultaneously.Setting The data were collected in three tertiary hospitals in Auckland, New Zealand in 2016 and included 60 teams observed in 60 different cases with an equal number of teams (n=20) per site. …”
    Get full text
    Article
  8. 88

    Effectiveness of nicotine salt vapes, cytisine, and a combination of these products, for smoking cessation in New Zealand: protocol for a three-arm, pragmatic, community-based randomised controlled trial by Natalie Walker, Amanda Calder, Joanne Barnes, George Laking, Varsha Parag, Chris Bullen

    Published 2023-09-01
    “…Eligible participants will be people who smoke daily (N = 800, 90% power) from throughout New Zealand, who are: aged ≥ 18 years, motivated to quit in the next two weeks, able to provide online consent, willing to use e-cigarettes and/or cytisine, and have daily access to a mobile phone. …”
    Get full text
    Article
  9. 89

    The Australian and New Zealand Fontan Registry Quality of Life Study: Protocol for a population-based assessment of quality of life among people with a Fontan circulation, their parents, and siblings by Daniel S J Costa, Kim Dalziel, Yves d’Udekem, David S Winlaw, David S Celermajer, Nadine A Kasparian, Diana Zannino, Rachel Bishop, Kate H Marshall, Susan R Woolfenden, Gary F Sholler

    Published 2022-09-01
    “…The objective of this study is to describe and develop a deeper understanding of the factors that contribute to quality of life (QOL) among children, adolescents and adults living with a Fontan circulation across Australia and New Zealand, their parents and siblings.Methods and Analysis This article presents the protocol for the Australian and New Zealand Fontan Registry (ANZFR) QOL Study, a cross-sectional, population-based study designed to examine QOL among people of all ages with a Fontan circulation, their parents and siblings. …”
    Get full text
    Article
  10. 90
  11. 91
  12. 92
  13. 93

    Using Days Alive and Out of Hospital to measure inequities and explore pathways through which inequities emerge after coronary artery bypass grafting in Aotearoa New Zealand: a secondary data analysis using a retrospective cohort by Sarah-Jane Paine, Luke Boyle, Alan Forbes Merry, Elana Curtis, Thomas Lumley, Jade Tamatea

    Published 2025-02-01
    “…Objectives To describe the use of days alive and out of hospital (DAOH) as a sensitive measure of equity of outcomes after surgery by comparing outcomes after a coronary artery bypass grafts (CABG) operation between Māori and non-Māori patients in Aotearoa New Zealand.Primary and secondary outcome measures We calculated unadjusted and risk-adjusted DAOH scores at three time points (30, 90 and 365 days) and compare values between Māori and non-Māori using data from the New Zealand Ministry of Health (MoH) over a 9 year period. …”
    Get full text
    Article
  14. 94
  15. 95
  16. 96
  17. 97

    Editor’s Welcome by Lorna Pairman, Angad S Chauhan

    Published 2024-12-01
    “…New Zealand Medical Student Journal…”
    Get full text
    Article
  18. 98
  19. 99
  20. 100

    Stucco keratosis: a common yet poorly understood phenomenon by Neakiry Kivi, Louise Reiche

    Published 2024-12-01
    “…New Zealand Medical Student Journal…”
    Get full text
    Article